Synthesis and biological activities of the respiratory chain inhibitor aurachin D and new ring versus chain analogues.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractAurachins are myxobacterial 3-farnesyl-4(1H)-quinolone derived compounds initially described as respiratory chain inhibitors, more specifically as inhibitors of various cytochrome complexes. They are also known as potent antibiotic compounds. We describe herein the first synthesis of aurachin D through a key Conrad-Limpach reaction. The same strategy was used to reach some ring as opposed to chain analogues, allowing for the description of structure-activity relationships. Biological screening of the analogues showed antiparasitic, cytotoxic, antibacterial and antifungal activities, and depletion of the mitochondrial membrane potential. The strongest activity was found on Plasmodium falciparum with a selectivity index of 345, compared to Vero cells, for the natural product and its geranyl analogue. The loss of mitochondrial membrane potential induced by aurachins in human U-2 OS osteosarcoma cells was studied, showing the best activity for aurachin D and a naphthalene analogue, yet without totally explaining the observed cytotoxic activity of the compounds. Finally, a synthetic entry is given to the complete carboheterocyclic core of aurachin H through the N-oxidation/epoxidation of aurachin D and a shorter chain analogue, followed by subsequent biomimetic cyclization.
CitationSynthesis and biological activities of the respiratory chain inhibitor aurachin D and new ring versus chain analogues. 2013, 9:1551-8 Beilstein J Org Chem
AffiliationMuséum National d'Histoire Naturelle, Unité Molécules de Communication et Adaptation des Micro-organismes (UMR 7245 CNRS-MNHN), 57 rue Cuvier (CP 54), 75005 Paris, France.
The following license files are associated with this item:
- Semisynthesis and antiplasmodial activity of the quinoline alkaloid aurachin E.
- Authors: Höfle G, Bööhlendorf B, Fecker T, Sasse F, Kunze B
- Issue date: 2008 Nov
- Chemically unprecedented biocatalytic (AuaG) retro-[2,3]-Wittig rearrangement: a new insight into aurachin B biosynthesis.
- Authors: Katsuyama Y, Li XW, Müller R, Nay B
- Issue date: 2014 Nov 3
- Short-chain aurachin D derivatives are selective inhibitors of E. coli cytochrome bd-I and bd-II oxidases.
- Authors: Radloff M, Elamri I, Grund TN, Witte LF, Hohmann KF, Nakagaki S, Goojani HG, Nasiri H, Hideto Miyoshi, Bald D, Xie H, Sakamoto J, Schwalbe H, Safarian S
- Issue date: 2021 Dec 13
- Total synthesis of aurachins C, D, and L, and a structurally simplified analog of aurachin C.
- Authors: Enomoto M, Kitagawa W, Yasutake Y, Shimizu H
- Issue date: 2014
- New inhibitors of the quinol oxidation sites of bacterial cytochromes bo and bd.
- Authors: Meunier B, Madgwick SA, Reil E, Oettmeier W, Rich PR
- Issue date: 1995 Jan 24